Subclinical chikungunya virus infection during pregnancy: immune and clinical characterization in a prospective cohort

Introduction Mosquito-borne viral infections are a rising global public health challenge, particularly for pregnant women. Chikungunya virus (CHIKV) infection is expanding beyond endemic regions, but maternal–fetal immune responses and pregnancy outcomes remain poorly characterized, especially for asymptomatic cases. Methods We analyzed maternal blood samples collected longitudinally from early pregnancy, with paired placental and umbilical cord tissues, and cord blood obtained at delivery, in a prospective Singapore cohort. CHIKV infection was determined by reverse transcription polymerase chain reaction (RT-PCR) and serological screening. Maternal systemic immune responses were characterized by multiplex profiling of circulating immune mediators. Antibody levels and neutralizing responses were assessed in maternal and cord blood sera, alongside clinical data on pregnancy and infant outcomes. Results and discussion Among 176 participants, three (1.7%) had laboratory evidence of CHIKV infection during pregnancy and nine (5.1%) had evidence of prior infection. No vertical transmission was detected, with undetectable CHIKV RNA and neonatal IgM levels in cord blood. Maternal and cord sera exhibited CHIKV-neutralizing activity, and a positive correlation between maternal and cord IgG titers supported transplacental transfer of IgG. In the three cases of infection during pregnancy, cytokine profiling suggested an attenuation of Th1-associated mediators while preserving factors involved in fetoplacental development. These maternal CHIKV infection cases experienced uncomplicated pregnancies, and all exposed infants were born appropriate for gestational age and achieved expected developmental milestones up to 12 months. Conclusion: Subclinical maternal CHIKV infection during pregnancy may not be associated with vertical transmission or adverse early clinical outcomes, and immune profiling suggests a potentially calibrated maternal immune response.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1993288
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Subclinical chikungunya virus infection during pregnancy: immune and clinical characterization in a prospective cohort

Stacey K.H. Tay, Benedict Yan, Shiao‐Yng Chan, Lisa F. P. Ng et al.
Frontiers in Immunology
Mosquito-borne diseases and control
article

Subclinical chikungunya virus infection during pregnancy: immune and clinical characterization in a prospective cohort

Stacey K.H. Tay, Benedict Yan, Shiao‐Yng Chan, Lisa F. P. Ng, Liang Hui Loo, Hannah E. J. Yong, Eu‐Leong Yong, Jiun Lee, Paul Anantharajah Tambyah, Siew‐Wai Fong, Sarah Tan, Nicholas Kim‐Wah Yeo, Evelyn Chung Ning Law, Anna X. Y. Loo, Ka Lip Chew
article en

Abstract

Introduction Mosquito-borne viral infections are a rising global public health challenge, particularly for pregnant women. Chikungunya virus (CHIKV) infection is expanding beyond endemic regions, but maternal–fetal immune responses and pregnancy outcomes remain poorly characterized, especially for asymptomatic cases. Methods We analyzed maternal blood samples collected longitudinally from early pregnancy, with paired placental and umbilical cord tissues, and cord blood obtained at delivery, in a prospective Singapore cohort. CHIKV infection was determined by reverse transcription polymerase chain reaction (RT-PCR) and serological screening. Maternal systemic immune responses were characterized by multiplex profiling of circulating immune mediators. Antibody levels and neutralizing responses were assessed in maternal and cord blood sera, alongside clinical data on pregnancy and infant outcomes. Results and discussion Among 176 participants, three (1.7%) had laboratory evidence of CHIKV infection during pregnancy and nine (5.1%) had evidence of prior infection. No vertical transmission was detected, with undetectable CHIKV RNA and neonatal IgM levels in cord blood. Maternal and cord sera exhibited CHIKV-neutralizing activity, and a positive correlation between maternal and cord IgG titers supported transplacental transfer of IgG. In the three cases of infection during pregnancy, cytokine profiling suggested an attenuation of Th1-associated mediators while preserving factors involved in fetoplacental development. These maternal CHIKV infection cases experienced uncomplicated pregnancies, and all exposed infants were born appropriate for gestational age and achieved expected developmental milestones up to 12 months. Conclusion: Subclinical maternal CHIKV infection during pregnancy may not be associated with vertical transmission or adverse early clinical outcomes, and immune profiling suggests a potentially calibrated maternal immune response.

Frontiers in ImmunologyVol. 17
Agency for Science, Technology and Research (SG), National University of Singapore (SG), National University Hospital (SG), National University Health System (SG), Infectious Diseases Labs (SG)
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon